CIK 0000818686 · Large accelerated filer
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sign in to watch- Ticker
- TEVA
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- operating
- Phone
- 972 (3) 914-8213
- Business address
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
- Former names
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,923,078
- in 11 filings, $11.2M under 10b5-1 plans
Net −$33,923,078. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-05 | Francis Richard D President and CEO | Sale 10b5-1 | −8,259 | $15.91 | $131K | 271,783 |
| 2025-03-04 | Weiss Amir Chief Accounting Officer | Option exercise | +10,676 | 21,034 | ||
| 2025-03-04 | Weiss Amir Chief Accounting Officer | Option exercise | +5,650 | 26,684 | ||
| 2025-03-04 | Weiss Amir Chief Accounting Officer | Option exercise · Restricted Share Units | −10,676 | 10,679 | ||
| 2025-03-04 | Weiss Amir Chief Accounting Officer | Option exercise · Restricted Share Units | −5,650 | 16,950 | ||
| 2025-03-04 | Fox Christine EVP, Head of U.S. Commercial | Option exercise 10b5-1 | +20,461 | 64,565 | ||
| 2025-03-04 | Fox Christine EVP, Head of U.S. Commercial | Sale 10b5-1 | −4,034 | $15.73 | $63K | 60,531 |
| 2025-03-04 | Fox Christine EVP, Head of U.S. Commercial | Option exercise · Restricted Share Units 10b5-1 | −20,461 | 61,384 | ||
| 2025-03-04 | McAvoy David R. EVP, Chief Legal Officer | Option exercise 10b5-1 | +16,741 | 16,741 | ||
| 2025-03-04 | McAvoy David R. EVP, Chief Legal Officer | Sale 10b5-1 | −3,150 | $15.73 | $50K | 13,591 |
| 2025-03-04 | McAvoy David R. EVP, Chief Legal Officer | Option exercise · Restricted Share Units 10b5-1 | −16,741 | 50,223 | ||
| 2025-03-04 | Kalif Eliyahu Sharon EVP, Chief Financial Officer | Option exercise | +33,512 | 231,253 | ||
| 2025-03-04 | Kalif Eliyahu Sharon EVP, Chief Financial Officer | Option exercise | +23,251 | 254,504 | ||
| 2025-03-04 | Kalif Eliyahu Sharon EVP, Chief Financial Officer | Option exercise | +183,169 | 437,673 | ||
| 2025-03-04 | Kalif Eliyahu Sharon EVP, Chief Financial Officer | Option exercise · Restricted Share Units | −33,512 | 33,512 | ||
| 2025-03-04 | Kalif Eliyahu Sharon EVP, Chief Financial Officer | Option exercise · Restricted Share Units | −23,251 | 69,754 | ||
| 2025-03-04 | Kalif Eliyahu Sharon EVP, Chief Financial Officer | Option exercise · Restricted Share Units | −183,169 | 0 | ||
| 2025-03-04 | Hughes Eric A See "Remarks" | Option exercise 10b5-1 | +23,251 | 23,251 | ||
| 2025-03-04 | Hughes Eric A See "Remarks" | Sale 10b5-1 | −15,174 | $15.73 | $239K | 8,077 |
| 2025-03-04 | Hughes Eric A See "Remarks" | Option exercise · Restricted Share Units 10b5-1 | −23,251 | 69,754 |
Page 16 of 76 · 1,517 trades